Instructions for use of Lao Lucius version of ritexitinib

Ritexitinib is a targeted drug specially used to treat severe alopecia areata and is suitable for adults and adolescents 12 years old and above. The drug promotes hair growth by regulating the immune system and inhibiting pathological reactions that lead to hair loss. In order to allow more patients to receive treatment, Lucius Laos has launched a relatively affordable version of ritexitinib.

For the Lao version of ritexitinib, the recommended dose is 50 mg once daily Patients can choose to take it before or after a meal. When taking, swallow the capsule whole and do not chew, crush or destroy its integrity to ensure effective release and absorption of the drug. If you accidentally miss a dose, you should take it as soon as possible, but if it is less than 8 hours before the next dose, skip the missed dose and resume medication at your regular time. In order to ensure the continuity of treatment, it is recommended that patients adhere to regular medication and avoid missing doses. If a temporary interruption of treatment is required, interruptions of less than 6 weeks usually do not significantly affect scalp hair regrowth.

Some special circumstances require special attention when using rituxitinib. This drug is not recommended for patients with severe hepatic impairment (e.g. Child Pugh class C). In addition, if a short-term interruption of treatment is required, it is best to conduct an evaluation under the guidance of a doctor to ensure safety. During use, this medication should be avoided in any patient with a known hypersensitivity to ritexitinib or its components.

During the use of rituxitinib, patients should also pay attention to interactions with other drugs. A variety of drugs, including prescription drugs, over-the-counter drugs, vitamins, and herbal products, may affect the efficacy of ritexitinib, so the doctor must be informed of all other drugs used, especially CYP3A substrates, CYP3A inducers, and CYP1A2 substrates. At the same time, ritexitinib should not be used in combination with other JAK inhibitors, biological immunomodulators, cyclosporine or other potent immunosuppressants to prevent possible side effects and drug interactions.

While taking ritexitinib, patients may experience some common side effects, such as headache, diarrhea, acne, rash, folliculitis, fever, eczema, dizziness, shingles, decreased red blood cells, and oral ulcers. If obvious discomfort occurs, you should seek medical treatment in time to ensure good health.

Currently, the market price of a box of generic ritexitinib is approximately RMB 800 to 900, and the specific price may change due to exchange rate fluctuations. It is recommended to purchase through formal channels and pay attention to identify the authenticity of the medicine.

References:

https://www.drugs.com/pro/litfulo.html#S6.1